Welcome!

News Feed Item

President's Cancer Panel Issues Urgent Call to Action to Increase HPV Vaccination

Report Outlines Recommendations to Overcome Barriers and Support Cancer Prevention Efforts

WASHINGTON, Feb. 10, 2014 /PRNewswire-USNewswire/ -- Achieving widespread HPV (human papillomavirus) vaccination is one of the most profound opportunities for cancer prevention, according to a report released today by the President's Cancer Panel.  The Panel's report, Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer, issues an urgent call for energizing efforts to reach the HPV vaccines' potential to save lives and prevent millions of avoidable cancers and HPV-related conditions in men and women. One in four people in the U.S. are infected with at least one type of HPV, a group of viruses linked to multiple cancers and other diseases. The report examines underuse of HPV vaccines, identifies key barriers to increasing vaccine uptake, and provides actionable recommendations for overcoming these obstacles.

"Today, there are two safe, effective, approved vaccines that prevent infection by the two most prevalent cancer-causing types, yet vaccination rates are far too low," said Barbara K. Rimer, DrPH, chair of the President's Cancer Panel. "We are confident that if HPV vaccination for girls and boys is made a public health priority, hundreds of thousands will be protected from these HPV-associated diseases and cancers over their lifetimes."

According to the report, based on data from the Centers for Disease Control and Prevention, in 2012 only about one-third of 13- to 17-year-old girls in the U.S. received all three recommended doses of HPV vaccine.  These rates fall considerably short of the U.S. Department of Health and Human Services Healthy People 2020 goal of having 80 percent of 13- to 15-year-old girls fully vaccinated against HPV.  Immunization rates for boys are even lower – less than 7 percent of boys ages 13-17 completed the vaccine series in 2012 (although the vaccine was approved for males more recently than for females).

The CDC estimates that increasing HPV vaccination rates from current levels to 80 percent would prevent an additional 53,000 future cervical cancer cases in the U.S. among girls who now are 12 years of age or younger, over the course of their lifetimes.  Thousands of cases of other HPV-associated cancers in the U.S., a growing proportion of which will occur in males, also likely would be prevented within the same timeframe.

The Panel's report outlines three critical goals that must be achieved to increase HPV vaccine uptake – Reducing missed clinical opportunities to recommend/administer HPV vaccines; Increasing parents'/adolescents' acceptance of HPV vaccines; and Maximizing access to HPV vaccination services – with the ultimate goal being completion of the full three-dose series by all age-eligible adolescents.

Key Findings and Recommendations:                       

  • According to the CDC, missed clinical opportunities are the most important reason why the U.S. has not achieved high rates of HPV vaccine uptake. As many as two-thirds of 11- and 12-year-old vaccine-eligible girls may not be receiving HPV vaccines at healthcare visits during which they receive at least one other vaccine. The Panel recommends targeted efforts, including communications strategies for physicians and other relevant health professionals, to increase dramatically the proportion of health providers who strongly recommend HPV vaccines for age-eligible adolescents. Use of EHRs (electronic health records) and immunization information systems can help to avoid missed opportunities for HPV vaccination and facilitate completion of the three dose regimen.
  • Parents' and other caregivers' knowledge, attitudes, and beliefs affect whether children receive vaccines, including HPV vaccines. Studies have provided insights into parents' views, including that some parents of young adolescents may believe they can wait to vaccinate their children against HPV. To increase HPV vaccine acceptance among parents, caregivers, and adolescents, the Panel recommends targeted efforts, including the deployment of integrated, comprehensive communications strategies, using social media, print, electronic communications and the persuasive authority of health care providers interacting with empowered patients.
  • Vaccines should be available where adolescents receive healthcare. It should be convenient to initiate and complete the HPV vaccine series, and cost should not be a barrier. The Panel recommends increasing the range of venues and providers for HPV vaccination, including venues outside the medical home, such as pharmacies. A 2012 survey of representatives of state pharmacy organizations in all 50 states and the District of Columbia found that pharmacists in more than one-third of states were not permitted to administer HPV vaccines to 12-year-old girls, though many of these states allowed pharmacists to provide HPV vaccines to women ages 19 and older.
  • Additionally, the burden of HPV-associated cancers extends beyond the borders of the United States, affecting populations in every country. The Panel calls for continued investment in and implementation of HPV vaccination programs in low-and middle-income countries, where the majority of HPV-associated cancer cases occur.

Starting on February 10, 2014, the complete report can be accessed at http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/index.htm.  Hard copies may be requested by writing to [email protected] or President's Cancer Panel, 9000 Rockville Pike, Building 31, Room B2B37, MSC 2590, Bethesda, MD 20892.

The President's Cancer Panel consists of three members appointed by the President of the United States. Current members are Barbara Rimer, DrPH, Chair, Dean and Alumni Distinguished Professor, UNC Gillings School of Global Public Health; Hill Harper, JD, cancer survivor, four-time New York Times Best-Selling Author, actor, and philanthropist; and Owen Witte, MD, Director, UCLA Eli and Edythe Broad Center of Regenerative Medicine, and Stem Cell Research Investigator, Howard Hughes Medical Institute. The Panel, established by the National Cancer Act of 1971, is an independent entity charged with monitoring the National Cancer Program and reporting annually to the President on any barriers to its execution.  The Panel does not conduct scientific research, and while support for the Panel is provided by the National Cancer Institute (NCI) at the National Institutes of Health under the Department of Health and Human Services, its conclusions and recommendations should not be inferred as policy or perspectives of the NCI.  More information about the Panel's role and background on its members can be found at pcp.cancer.gov.

SOURCE President's Cancer Panel

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Behera Rasananda is a technologist, a leader, a key note speaker has more than 20 years experience in across Government, Financial, Heath Care and Insurance Verticals. Mr. Behera has vast experience in Enterprise Cloud and Big Data solutions and Enterprise Architecture. Currently he works closely for Government Solutions on Enterprise Cloud for Federal Government Agency. Scientist Behera managed and partner with clients to make complete end to end solution and Migration to cloud both private sec...
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
As Enterprise business moves from Monoliths to Microservices, adoption and successful implementations of Microservices become more evident. The goal of Microservices is to improve software delivery speed and increase system safety as scale increases. Documenting hurdles and problems for the use of Microservices will help consultants, architects and specialists to avoid repeating the same mistakes and learn how and when to use (or not use) Microservices at the enterprise level. The circumstance w...
Today, we have more data to manage than ever. We also have better algorithms that help us access our data faster. Cloud is the driving force behind many of the data warehouse advancements we have enjoyed in recent years. But what are the best practices for storing data in the cloud for machine learning and data science applications?
"Avere Systems deals with data performance optimization in the cloud or on-premise. Even to this day many organizations struggle with what we call the problem of data gravity - 'Where should I put the data?' - because the data dictates ultimately where the jobs are going to run," explained Scott Jeschonek, Director Cloud Solutions at Avere Systems, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
For years the world's most security-focused and distributed organizations - banks, military/defense agencies, global enterprises - have sought to adopt cloud technologies that can reduce costs, future-proof against data growth, and improve user productivity. The challenges of cloud transformation for these kinds of secure organizations have centered around data security, migration from legacy systems, and performance. In our presentation, we will discuss the notion that cloud computing, properl...
"We began as LinuxAcademy.com about five years ago as a very small outfit. Since then we've transitioned into more of a DevOps training company - the technologies and the tooling around DevOps," explained Doug Vanderweide, an instructor at Linux Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
They say multi-cloud is coming, but organizations are leveraging multiple clouds already. According to a study by 451 Research, only 21% of organizations were using a single cloud. If you've found yourself unprepared for the barrage of cloud services introduced in your organization, you will need to change your approach to engaging with the business and engaging with vendors. Look at technologies that are on the way and work with the internal players involved to have a plan in place when the ine...
More and more companies are looking to microservices as an architectural pattern for breaking apart applications into more manageable pieces so that agile teams can deliver new features quicker and more effectively. What this pattern has done more than anything to date is spark organizational transformations, setting the foundation for future application development. In practice, however, there are a number of considerations to make that go beyond simply “build, ship, and run,” which changes how...
DevOps with IBMz? You heard right. Maybe you're wondering what a developer can do to speed up the entire development cycle--coding, testing, source code management, and deployment-? In this session you will learn about how to integrate z application assets into a DevOps pipeline using familiar tools like Jenkins and UrbanCode Deploy, plus z/OSMF workflows, all of which can increase deployment speeds while simultaneously improving reliability. You will also learn how to provision mainframe syste...
CloudEXPO New York 2018, colocated with DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
The best way to leverage your Cloud Expo presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering Cloud Expo and @ThingsExpo will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at Cloud Expo. Product announcements during our show provide your company with the most reach through our targeted audiences.